Phendimetrazine Tartrate Tablet
Product Images NDC 66267-394

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Phendimetrazine Tartrate (NDC 66267-394). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals, Inc,, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

C:\documents And Settings\avyas\desktop\phend-outsert\spl\phendimetrazine-image-a.jpg (3e594fab Figure 01)

Chemical structure of Phendimetrazine Tartrate, showing the molecular arrangement of the phendimetrazine moiety linked to the tartrate ion.*

FDA Label Image

C:\documents And Settings\avyas\desktop\phend-outsert\spl\phendimetrazine-image-b.jpg (3e594fab Figure 02)

FDA Label Image

Pdp (66267 394 60 K35)

Label for Phendimetrazine Tartrate 35 mg tablets manufactured by NuCare Pharmaceuticals, Inc. The label indicates a 60 count package and includes dosage instructions to take every 4 hours up to 3 times a day. It also shows the product number P0394060PED, NDC 66267-394-60, and storage instructions to keep at controlled temperature between 68-77°F. The tablets are round yellow scored and debossed with 'K 77'.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.